CD-801

DRUG2 trials

Sponsors

Shanghai Changzheng Hospital

Conditions

Advanced Hepatocellular Carcinoma

Early Phase 1

A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma

CompletedNCT06092112

Shanghai Changzheng HospitalAdvanced Hepatocellular Carcinoma

Start: 2023-10-13End: 2024-04-29Updated: 2025-04-24

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients

RecruitingNCT06418659

Shanghai Changzheng HospitalAdvanced Hepatocellular Carcinoma

Start: 2024-10-12End: 2026-12-31Target: 37Updated: 2025-04-24